Loading...

Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity

AIMS: To investigate the pharmacokinetics and safety of tolterodine and tolterodine metabolites after single-and multiple-dose administration in the absence and presence of ketoconazole, an inhibitor of cytochrome P450 (CYP) 3A4, in healthy volunteers with deficient CYP2D6 activity, i.e. poor metabo...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Brynne, N, Forslund, C, Hallén, B, Gustafsson, L L, Bertilsson, L
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Science Inc 1999
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014365/
https://ncbi.nlm.nih.gov/pubmed/10583027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1999.00053.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!